Archive for 2010/10


Surrogate Decision Makers Wish To Retain Authority In Decision To Stop Life-Support For Incapacitated And Critically Ill Patients

The decision to stop life-support for incapacitated and critically ill patients is, for surrogate decision makers, often fraught with moral and ethical uncertainty, and long-term emotional consequences...
(more...)


Pfizer Canada Introduces (Pr)Zmax SRTM

Pfizer Canada announced that PrZmax SR™ - a new antibiotic formulation that provides a convenient single-dose treatment for Acute Bacterial Sinusitis (ABS), Acute Bacterial Exacerbations of Chronic Bronchitis (ABECB) and Community Acquired Pneumonia (CAP) of mild severity - is now available in Canada...
(more...)


Researchers Generate IPSCs To Further Treatments For Lung Disease

A team of researchers from Boston University's Center for Regenerative Medicine and the Pulmonary Center have generated 100 new lines of human induced pluripotent stem cells (iPSC) from individuals with lung diseases, including cystic fibrosis and emphysema. The new stem cell lines could possibly lead to new treatments for these debilitating diseases...
(more...)


Amira Pharmaceuticals Announces Initiation Of Phase I Clinical Trial For AM152, A Novel LPA1 Antagonist

Amira Pharmaceuticals, Inc. announced today that it has initiated a Phase 1 clinical study with AM152, a novel LPA1 antagonist, in normal, healthy subjects. “We are excited to begin our journey exploring the therapeutic value of AM152, a potentially novel anti-fibrotic agent…


(more...)


Glucosamine Causes The Death Of Pancreatic Cells

High doses or prolonged use of glucosamine causes the death of pancreatic cells and could increase the risk of developing diabetes, according to a team of researchers at Université Laval's Faculty of Pharmacy. Details of this discovery were recently published on the website of the Journal of Endocrinology...
(more...)


Lotus Pharmaceuticals Receives SFDA Approval To Initiate Phase I Clinical Trials Of Asthma Drug R-Bambuterol

Lotus Pharmaceuticals, Inc...
(more...)


69 Health And Other Groups Urge EPA To Save Thousands Of Lives With Stronger Smog Standards

Sixty-nine organizations representing health, environmental, Latino and faith constituencies are urging the U.S. Environmental Protection Agency (EPA) to protect public health by issuing strong standards for smog (ground-level ozone)...
(more...)


New Class Of Biomolecules Triggered In Response To Respiratory Virus Infection

For the first time, scientists have discovered that a poorly understood class of RNA produced in a mammal's cells during a respiratory virus attack may affect the outcome of the infection. Their findings are reported in mBio, a journal of the American Society for Microbiology. RNA (ribonucleic acid) contains information transcribed from the cell's instruction manual, its DNA...
(more...)


Asthma Drug For Under 12s Not Recommended For NHS Use

Omalizumab (Xolair, Novartis Pharmaceuticals UK) is not recommended as a treatment for severely asthmatic children under the age of 12, according to new guidance published today (27 October)...
(more...)


The Canadian Lung Association: Is Radon A Hidden Danger In Your Home?

Radon gas exposure is the second-leading cause of lung cancer after smoking - yet awareness of this risk remains low among Canadians. To increase radon awareness, the Canadian Lung Association is launching a new social media campaign and urging Canadians to test their homes this fall...
(more...)